GT Life Sciences Summit Europe 2025
            Ready for the future? Navigating the challenges and opportunities in Life Sciences.
The life sciences industry is evolving rapidly — driven by innovation, digitalization, and global collaboration. Are you ready to navigate what’s next?
Join Greenberg Traurig Germany, LLP and the German Pharmaceutical Industry Association (BPI) for an exclusive, full-day summit in Berlin on November 10, 2025, bringing together leading voices from pharma, medtech, and biotech to explore the future of the European and transatlantic life sciences markets.
This year’s key topics include:
 
 
 
 
 
 
 
 
  
Transatlantic Trade & Regulation: Gain insights into current developments in trade between Europe and the US, as well as regulatory hurdles and challenges in the German and European healthcare market.
Innovation Strategies & IP: Learn how IP strategies differ in Europe and the US and get insights into the latest developments surrounding the FDA and the challenges for foreign companies in the US.
Pharma, MedTech & Digitalization: Join experts in discussing Germany's post-election pharma strategy, the future of EU HTA, digital health, and the effects of ESG rules on MedTech companies.
M&A, Financing & Investments: Learn more about cross-border deals, VC financing, IPOs in the US and Europe, and investment opportunities in the health services sector.
Future Technologies: Explore the opportunities and challenges of biotech & AI and learn how gene and cell therapies are influencing pricing and negotiation models.
Litigation: 
 Learn the latest trends and how to prepare now to lower the chance of litigation and mitigate risk. 
Join us for an insightful program featuring plenary sessions and interactive panel discussions with renowned GT speakers and industry experts, including:
Yao Li Ho | Managing Director - LYFE Capital
Kai Joachimsen | Chief Executive Officer - Bundesverband der Pharmazeutischen Industrie (German Pharmaceutical Industry Association)
Hilary Jones | Vice President Legal, Global Commercial and Regulatory Law - BioNTech UK Ltd
Andreas Köhler | Former Chairman of the Board - Kassenärztliche Bundesvereinigung (German National Association of Statutory Health Insurance Physicians)
Matthias Krings | Senior Partner & Co-Founder - Catenion Middle East
Meinrad Lugan | Honorary Chairman, BVMed - Bundesverband Medizintechnologie (German Medical Technology Association) and former Board Member of B.Braun Group
Pia Maier | Principal Govermental Affairs Specialist DACH - Medtronic
Marc-Pierre Möll | Managing Director - BVMed - Bundesverband Medizintechnologie (German Medical Technology Association)
Stefan Neudörfer | Executive Director, Head Market Access & Pricing Europe - CSL Behring
Brian O'Shaughnessy | Chief Commercial Officer - Uniphar Group
Jeffrey Prokop | Vice President, Global Head, Litigation & Government Investigations - Alcon
Robert Rabiner | Founder and CTO - IlluminOss Medical
Stefan Schrettle | Partner in L.E.K. Consulting and heads the Munich office
Matthias Wilken | Managing Director, Market Access, Markets and Supply | Business Unit Manager, Scientific Issues SGB V Bundesverband der Pharmazeutischen Industrie (German Pharmaceutical Industry Association)
Take advantage of this unique opportunity to connect with decision-makers, exchange ideas, and shape the future of life sciences — followed by an evening networking reception.